Effectiveness of a 10‐Day Melarsoprol Schedule for the Treatment of Late‐Stage Human African Trypanosomiasis: Confirmation from a Multinational Study (ImpamelII)

Abstract

BackgroundTreatment of late-stage human African trypanosomiasis (HAT) with melarsoprol can be improved by shortening the regimen. A previous trial demonstrated the safety and efficacy of a 10-day treatment schedule. We demonstrate the effectiveness of this schedule in a noncontrolled, multinational drug-utilization study